Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia

J Rehabil Med. 2010 Apr;42(4):332-8. doi: 10.2340/16501977-0521.

Abstract

Objective: To measure the effect of intensive therapy and the lasting effect of a standardized functional training programme with vs. without the addition of chemodernervation of the muscles of the forearm and hand.

Patients and methods: Twenty children with spastic hemiplegia, aged 4-16 years, were matched for baseline characteristics and randomized to standardized task-oriented therapy for 6 months with or without botulinum toxin injections. Dynamic kinematic outcome measures were: speed, accuracy, end-point spread and performance. Measurements of active and passive range of motion, stretch-restricted angle of the elbow and wrist, Ashworth scores and Melbourne Assessment of Unilateral Upper Limb Function were made. All measures were performed at baseline, 2 weeks after injection of botulinum toxin and after 6 months (at the end of therapy), and 3 months after end of the therapy.

Results: Clinical measures showed improvement in both groups. However, no significant differences emerged between groups on functional measures. Directly after the botulinum toxin injection all kinematic outcome measures showed a decrease, but baseline values were re-established during the therapy period. After botulinum toxin injections a temporarily significant greater increase in speed and performance was found. These results illustrate the need for further quantitative research into the effects of botulinum toxin.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Activities of Daily Living
  • Adolescent
  • Botulinum Toxins, Type A / therapeutic use*
  • Cerebral Palsy / drug therapy*
  • Cerebral Palsy / physiopathology
  • Cerebral Palsy / rehabilitation
  • Child
  • Child, Preschool
  • Follow-Up Studies
  • Hemiplegia / drug therapy*
  • Hemiplegia / physiopathology
  • Hemiplegia / rehabilitation
  • Humans
  • Motor Skills
  • Neuromuscular Agents / therapeutic use*
  • Outcome Assessment, Health Care
  • Range of Motion, Articular / physiology
  • Task Performance and Analysis
  • Treatment Outcome
  • Upper Extremity / physiopathology

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A